South Africa has kicked off its vaccination campaign against COVID-19 by injecting healthcare workers with the shot developed by Johnson & Johnson as part of an observational study. The first healthcare worker was inoculated at 1pm (11:00 GMT) on Wednesday at the Khayelitsha District Hospital in Cape Town, following the arrival of 80,000 vaccine doses at Johannesburg’s international airport the night before. President Cyril Ramaphosa, along with Health Minister Zweli Mkhize and Deputy Health Minister Joe Phaahla, were also among the first to be vaccinated. The single-dose vaccine developed by Johnson & Johnson is the first to be used outside a clinical trial and is not yet approved for general use anywhere in the world. The company’s jab has been shown to offer 57 percent protection against moderate to severe COVID-19 infections caused by a more transmissible new variant, the 501Y.V2 also known as B.1.351, which counts for 90 percent of cases in the country. The Johnson & Johnson vaccine, along with the one developed by Novavax (50 percent protection) are the only two vaccines that have shown efficacy in clinical trials held in South Africa against the new variant.
SOURCE:AL JAZEERA
More Stories
Economic Perks of Growing Cycling Culture in North Africa
The Bank of Uganda Lowers Limits on the Value of Cheque Payments to Promote e-payments
Four Industrial Policy Regimes that have Shaped Africa
Ex Standard Bank Leader Cleared in Mozambique Price Fixing
Zanzibar and Pemba are about to Become a Test Site for a Mobile Internet Network
East Africa’s Mineral Deposits at the Centre of Future-facing Commodities
A Scramble for Controlling Interest in Nigeria’s Oldest Bank
Top Risks Facing South Africa
New Scheme to Save Zimbabwe’s Botched Land Reform
The First Floating LNG Facility is Deployed in the Deep Waters of the African Continent
The EU Lifts Air Travel Bans on Southern African States
Senegal’s Illustrious Portfolio of Architecture